PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2009 | 69 | 3 |
Tytuł artykułu

Neuroprotective effects of AAV2-h1L-10 in mouse model of Parkinson's disease

Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Parkinson’s disease (PD) is a neurodegenerative disorder which is characterized by abnormal loss of nigrostriatal dopamine (DA) neurons, accompanied by DA defi ciency in the striatum. The pathomechanism by which DA neurons degenerate is still unknown, however, there is increasing evidence that is possible immunological mechanisms involvement in the etiopathogenesis of PD. The aim of the present study was to examine the effect of an adeno-associated viral type-2 (AAV2) vector containing human interleukin-10 (hIL-10) gene on dopaminergic system restoration in the murine model of PD induced by by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Male C57BL/6 mice 12 months-old were used in this study. MPTP was injected in four intraperitoneal injections at 1-h intervals. AAV2-hIL-10 vector was bilaterally administered into striatum at 14, 21 or 28 days prior to MPTP intoxication. Animals were sacrifi ced at 7 days following MPTP injection. Striatal DA, DOPAC, HVA concentrations were quantifi ed by HPLC method; tyrosine hydroxylase (TH) mRNA expression was measured by RT-PCR method. MPTP treatment dramatically decreased DA concentration, signifi cantly decreased TH mRNA gene expression. AAV2-hIL-10 exerted a neuroprotective effect upon dopaminergic system (lower decrease in DA concentration). Additionally, viral vector administration prevented depletion of TH mRNA expression induced by MPTP. Our data suggest that AAV2-hIL-10 may play a neuroprotective role in MPTP mouse model of PD.
Słowa kluczowe
Wydawca
-
Rocznik
Tom
69
Numer
3
Opis fizyczny
p.345
Twórcy
autor
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
  • Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
autor
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
autor
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
autor
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
  • Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
autor
  • Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA
  • Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
  • Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
  • Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland
Bibliografia
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-fbe0cfe2-83de-4895-850b-ecc3dd5c19b4
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.